Cefdinir for Oral Suspension USP recall
Cefdinir for Oral Suspension USP, 125 mg/5mL, packaged in a) 60 mL bottle (NDC 68180-722-20), b) 100 mL bottle (NDC 68180-722-10), Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202, United States, Manufactured by: Lupin Limited, Mandideep 462 046 INDIA
Why was Cefdinir for Oral Suspension USP recalled?
Presence of Foreign substance: identified as a dead ant.
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot #: a) F900153, Exp 11/20; b) F802327, F802328, F802329, Exp 11/20
- Product
- Cefdinir for Oral Suspension USP, 125 mg/5mL, packaged in a) 60 mL bottle (NDC 68180-722-20), b) 100 mL bottle (NDC 68180-722-10), Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202, United States, Manufactured by: Lupin Limited, Mandideep 462 046 INDIA
- Recalling firm
- Lupin Pharmaceuticals Inc.
- Quantity
- a) 4074 bottles b) 30,300 bottles
- Distribution
- Product was distributed to major distributors/wholesalers throughout the United States.
- Recall date
- November 13, 2019
- Classification
- Class III
- Status
- Terminated
- Agency
- FDA (drug)